Validation of the CUETO scoring model for predicting recurrence and progression in T1G3 urothelial carcinoma of the bladder.


Servicio de Urología, Fundación Puigvert, Universidad Autónoma de Barcelona, Barcelona, España. Electronic address: [Email]


Various studies tried to validate Club Urológico Español de Tratamiento Oncológico (CUETO) tables, yet, none of this papers focused on the high and very high risk bladder cancers. The aim of the study was to externally validate the CUETO model for predicting disease recurrence and progression in group of T1G3 tumors treated with BCG immunotherapy.


Bacillus Calmette-Guérin,Bacilo Calmette-Guérin,Bladder cancer,Cáncer de vejiga,Evaluación de riesgos,Progresión,Progression,Recidiva,Recurrence,Risk assessment,Validación,Validation,

OUR Recent Articles